Royalty Pharma (RPRX) Treasury Shares (2019 - 2026)

Royalty Pharma has disclosed Treasury Shares across 8 years of filings, most recently posting $2.7 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.7 million, up 2.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 2.07% YoY), and the FY2025 annual result was $2.6 million, down 1.88% from the prior year.
• Treasury Shares came in at $2.7 million for Q1 2026 at Royalty Pharma, up from $2.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $21.5 million in Q2 2025 to a low of $3.1 million in Q2 2024.
• The 4-year median for Treasury Shares is $9.4 million (2023), against an average of $12.1 million.
• Across the five-year window, Treasury Shares gained 15.98% in 2022 and decreased 6.31% in 2023, its largest moves.
• Royalty Pharma's Treasury Shares stood at $2.8 million in 2022, then decreased by 6.31% to $2.6 million in 2023, then increased by 1.26% to $2.7 million in 2024, then retreated by 1.88% to $2.6 million in 2025, then advanced by 3.71% to $2.7 million in 2026.
• The last three Treasury Shares figures came in at $2.7 million (Q1 2026), $2.6 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.